HERM ROSENMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HERM ROSENMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HERM ROSENMAN. HERM ROSENMAN is Director in VIVUS INC ($VVUS) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and in Oxford Immunotec Global PLC ($OXFD) and Director in Oxford Immunotec Global PLC ($OXFD) and in Natera, Inc. ($NTRA) and Chief Financial Officer in Natera, Inc. ($NTRA) and Director in Natera, Inc. ($NTRA) and Director in DermTech, Inc. ($CNACU).
Latest Insider Trading Transactions of HERM ROSENMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DMTK, INFI, NTRA, OXFD, VVUS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | NTRA | Natera, Inc. | ROSENMAN HERM | Option Exercise | A | 94.14 | 2,614 | 246,082 | 2,614 | ||
Jun 02 2021 | NTRA | Natera, Inc. | ROSENMAN HERM | Option Exercise | A | 0.00 | 1,307 | 0 | 1,307 | ||
Jun 02 2021 | NTRA | Natera, Inc. | ROSENMAN HERM | Option Exercise | M | 0.00 | 2,856 | 0 | 0 | ||
Jun 02 2021 | NTRA | Natera, Inc. | ROSENMAN HERM | Buy | M | 0.00 | 2,856 | 0 | 51,275 | 48.4 K to 51.3 K (+5.90 %) | |
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 12.96 | 9,494 | 123,042 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.17 | 7,457 | 105,666 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 16.86 | 7,457 | 125,725 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 15.40 | 14,914 | 229,676 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 15.40 | 7,457 | 114,838 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.44 | 7,457 | 107,679 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.49 | 7,457 | 108,052 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 14.46 | 7,457 | 107,828 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Option Exercise | D | 8.65 | 7,457 | 64,503 | 0 | ||
Mar 12 2021 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Sell | D | 22.00 | 4,081 | 89,782 | 0 | 4.1 K to 0 (-100.00 %) | |
Jun 19 2020 | DMTK | DermTech, Inc. | ROSENMAN HERM | Director | Grant | A | 0.00 | 8,000 | 0 | 43,224 | 35.2 K to 43.2 K (+22.71 %) |
Jun 16 2020 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 40.93 | 5,712 | 233,792 | 5,712 | |
Jun 16 2020 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 0.00 | 2,856 | 0 | 2,856 | |
Feb 24 2020 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 2.41 | 15,000 | 36,150 | 15,000 | |
Feb 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Grant | A | 0.00 | 6,000 | 0 | 35,224 | 29.2 K to 35.2 K (+20.53 %) |
Jan 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 17,703 | 0 | 0 | |
Jan 03 2020 | CNACU | DermTech, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 17,703 | 0 | 29,224 | 11.5 K to 29.2 K (+153.66 %) |
Dec 03 2019 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 7,278 | 0 | 0 | |
Dec 03 2019 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 7,278 | 0 | 48,419 | 41.1 K to 48.4 K (+17.69 %) |
Jun 19 2019 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
May 29 2019 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 22.83 | 22,000 | 502,260 | 22,000 | |
Apr 16 2019 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 0.00 | 7,278 | 0 | 7,278 | |
Oct 29 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 3.53 | 15,000 | 52,950 | 15,000 | |
Sep 18 2018 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 0.00 | 5,785 | 0 | 5,785 | |
Sep 18 2018 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 24.42 | 11,169 | 272,747 | 11,169 | |
Jul 03 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.70 | 25,000 | 17,500 | 50,000 | |
Jul 03 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.70 | 25,000 | 17,500 | 311,671 | 286.7 K to 311.7 K (+8.72 %) |
Jun 21 2018 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
Jun 05 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | P | 0.77 | 50,000 | 38,500 | 50,000 | 0 to 50 K |
Jun 05 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | P | 0.77 | 50,000 | 38,500 | 50,000 | 0 to 50 K |
May 31 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | P | 0.79 | 50,000 | 39,500 | 286,671 | 236.7 K to 286.7 K (+21.13 %) |
May 23 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.70 | 75,000 | 52,500 | 75,000 | |
May 23 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | P | 0.81 | 100,000 | 81,000 | 236,671 | 136.7 K to 236.7 K (+73.17 %) |
May 23 2018 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.70 | 75,000 | 52,500 | 136,671 | 61.7 K to 136.7 K (+121.61 %) |
Oct 31 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 0 | |
Oct 31 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 0.70 | 150,000 | 105,000 | 150,000 | |
Oct 31 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 0.70 | 4,403 | 3,082 | 61,671 | 66.1 K to 61.7 K (-6.66 %) |
Oct 31 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 12,500 | 0 | 66,074 | 53.6 K to 66.1 K (+23.33 %) |
Aug 10 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 12,500 | |
Aug 10 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.01 | 4,403 | 4,447 | 53,574 | 58 K to 53.6 K (-7.59 %) |
Aug 10 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 12,500 | 0 | 57,977 | 45.5 K to 58 K (+27.49 %) |
Jun 19 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Jun 19 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.17 | 4,403 | 5,152 | 45,477 | 49.9 K to 45.5 K (-8.83 %) |
Jun 19 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 12,500 | 0 | 49,880 | 37.4 K to 49.9 K (+33.44 %) |
Jun 08 2017 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
Apr 19 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | A | 7.86 | 16,530 | 129,926 | 16,530 | |
Apr 10 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
Apr 10 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Sell | S | 8.55 | 1,809 | 15,467 | 41,141 | 43 K to 41.1 K (-4.21 %) |
Apr 10 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 5,000 | 0 | 42,950 | 38 K to 43 K (+13.18 %) |
Mar 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Mar 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Sell | S | 9.73 | 1,805 | 17,563 | 37,950 | 39.8 K to 38 K (-4.54 %) |
Mar 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 5,000 | 0 | 39,755 | 34.8 K to 39.8 K (+14.39 %) |
Feb 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
Feb 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Sell | S | 8.95 | 1,805 | 16,155 | 34,755 | 36.6 K to 34.8 K (-4.94 %) |
Feb 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Director | Buy | M | 0.00 | 5,000 | 0 | 36,560 | 31.6 K to 36.6 K (+15.84 %) |
Jan 18 2017 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jan 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
Jan 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 11.87 | 1,849 | 21,948 | 31,560 | 33.4 K to 31.6 K (-5.53 %) |
Jan 06 2017 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 33,409 | 28.4 K to 33.4 K (+17.60 %) |
Dec 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 20,000 | |
Dec 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 11.83 | 1,828 | 21,625 | 28,409 | 30.2 K to 28.4 K (-6.05 %) |
Dec 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 30,237 | 25.2 K to 30.2 K (+19.81 %) |
Nov 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 25,000 | |
Nov 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 7.98 | 1,852 | 14,779 | 25,237 | 27.1 K to 25.2 K (-6.84 %) |
Nov 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 27,089 | 22.1 K to 27.1 K (+22.64 %) |
Nov 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 3,125 | 0 | 0 | |
Nov 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.05 | 1,100 | 1,155 | 29,283 | 30.4 K to 29.3 K (-3.62 %) |
Nov 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 3,125 | 0 | 30,383 | 27.3 K to 30.4 K (+11.46 %) |
Oct 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 30,000 | |
Oct 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 11.53 | 1,773 | 20,444 | 20,278 | 22.1 K to 20.3 K (-8.04 %) |
Oct 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 22,051 | 17.1 K to 22.1 K (+29.32 %) |
Oct 04 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Oct 04 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.14 | 1,100 | 1,254 | 27,258 | 28.4 K to 27.3 K (-3.88 %) |
Oct 04 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 3,125 | 0 | 28,358 | 25.2 K to 28.4 K (+12.38 %) |
Sep 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 35,000 | |
Sep 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 10.21 | 1,822 | 18,603 | 17,051 | 18.9 K to 17.1 K (-9.65 %) |
Sep 07 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 18,873 | 13.9 K to 18.9 K (+36.04 %) |
Sep 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
Sep 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.06 | 1,111 | 1,178 | 25,233 | 26.3 K to 25.2 K (-4.22 %) |
Sep 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 3,125 | 0 | 26,344 | 23.2 K to 26.3 K (+13.46 %) |
Aug 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 40,000 | |
Aug 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 12.98 | 1,833 | 23,792 | 13,873 | 15.7 K to 13.9 K (-11.67 %) |
Aug 04 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 15,706 | 10.7 K to 15.7 K (+46.70 %) |
Aug 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 3,125 | 0 | 9,375 | |
Aug 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.07 | 1,100 | 1,177 | 23,219 | 24.3 K to 23.2 K (-4.52 %) |
Aug 02 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 3,125 | 0 | 24,319 | 21.2 K to 24.3 K (+14.74 %) |
Jul 08 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 45,000 | |
Jul 08 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 12.10 | 1,824 | 22,070 | 10,706 | 12.5 K to 10.7 K (-14.56 %) |
Jul 08 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 12,530 | 7.5 K to 12.5 K (+66.40 %) |
Jul 05 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 3,125 | 0 | 12,500 | |
Jul 05 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.12 | 1,100 | 1,232 | 21,194 | 22.3 K to 21.2 K (-4.93 %) |
Jul 05 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 3,125 | 0 | 22,294 | 19.2 K to 22.3 K (+16.30 %) |
Jun 29 2016 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
Jun 03 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 50,000 | |
Jun 03 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Sell | S | 12.04 | 1,806 | 21,744 | 7,530 | 9.3 K to 7.5 K (-19.34 %) |
Jun 03 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 9,336 | 4.3 K to 9.3 K (+115.31 %) |
Jun 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | M | 0.00 | 21,875 | 0 | 15,625 | |
Jun 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Sell | D | 1.23 | 7,706 | 9,478 | 19,169 | 26.9 K to 19.2 K (-28.67 %) |
Jun 01 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Buy | M | 0.00 | 21,875 | 0 | 26,875 | 5 K to 26.9 K (+437.50 %) |
May 16 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 55,000 | |
May 16 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Payment of Exercise | F | 11.19 | 1,811 | 20,263 | 3,189 | 5 K to 3.2 K (-36.22 %) |
May 16 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 03 2016 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
Apr 12 2016 | NTRA | Natera, Inc. | ROSENMAN HERM | Chief Financial Off ... | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Nov 03 2015 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
Jun 12 2015 | OXFD | Oxford Immunotec G ... | ROSENMAN HERM | Director | Option Exercise | A | 14.17 | 7,457 | 105,666 | 7,457 | |
May 29 2015 | VVUS | VIVUS INC | ROSENMAN HERM | Director | Option Exercise | A | 2.53 | 25,000 | 63,250 | 25,000 | |
May 12 2006 | INFI | INFINITY PHARMACEU ... | ROSENMAN HERM | Director | Option Exercise | A | 2.50 | 15,000 | 37,500 | 15,000 | |
May 13 2005 | INFI | INFINITY PHARMACEU ... | ROSENMAN HERM | Director | Option Exercise | A | 3.03 | 15,000 | 45,450 | 15,000 | |
Jun 08 2004 | INFI | INFINITY PHARMACEU ... | ROSENMAN HERM | Director | Option Exercise | A | 5.35 | 10,000 | 53,500 | 10,000 |
Page: 1